|Bid||41.83 x 800|
|Ask||41.85 x 1300|
|Day's range||41.32 - 42.62|
|52-week range||39.41 - 64.50|
|Beta (5Y monthly)||0.71|
|PE ratio (TTM)||10.73|
|Earnings date||24 Jun 2020 - 28 Jun 2020|
|Forward dividend & yield||1.83 (4.49%)|
|Ex-dividend date||17 Feb 2020|
|1y target est||49.67|
Testing for COVID-19, the serious respiratory illness cased by the new coronavirus, has been held back by a lack of test kits and other equipment. While more than 300,000 people in America have tested positive for the new coronavirus, officials believe a shortage of kits has undercounted cases. Testing, including at drive-through sites like these, is also seen as a key component for U.S. workers and restarting the economy as most states have ordered many non-essential businesses to close.
Ensuring the health and safety of its team members, customers and communities is Walgreens top priority, now more than ever. The company is committed to providing a safe environment in stores chain-wide, and is taking additional measures for team members on the frontlines of care, as well as those across its supply chain, as part of Walgreens broader efforts to support the communities it serves throughout the COVID-19 pandemic.
The company said retail sales in the United States dropped after March 21, before which consumers were stockpiling items in preparation for a lockdown. Meanwhile, retail sales at its UK business has plummeted 65% in the last 10 days. Walgreens executives said the situation was temporary as they fielded several questions from analysts on a conference call.
(Bloomberg) -- Walgreens Boots Alliance Inc. sank after executives said sales have started to decline at its drugstores as a result of the coronavirus pandemic, though the full impact on its business won’t be known for months.U.S. consumers had raced early last month to stock up on drugs, cleaning supplies and toilet paper as they prepared to stay at home to avoid getting or spreading Covid-19. Now, that rush appears to be ebbing.In the first three weeks of March, Walgreens’ comparable sales rose about 26%, Chief Financial Officer James Kehoe said on a call Thursday with Wall Street analysts, adding that health and grocery sales surged while discretionary categories like beauty slumped. However, sales began to fall in the last 10 days of March, declining at a mid-teens percentage rate.“Obviously, if this trend continues for an extended period, it will quickly offset the sales uplift seen in the first 21 days of March,” Kehoe said.Kehoe said the pharmacy business experienced similar trends, though less pronounced, with patients refilling prescriptions early.Shares fell 7% to $40.01 at 10:27 a.m. in New York. Since the beginning of 2020, the stock had declined 27% through the close of trading Wednesday.Earlier Thursday, Walgreens posted better-than-expected results for its second quarter but cautioned that the Covid-19 pandemic makes the future uncertain. The Deerfield, Illinois-based company said it would update its financial guidance in its next quarterly report. Previously, it had projected roughly flat growth in adjusted earnings per share.Chief Executive Officer Stefano Pessina said while the company’s second-quarter results were better than expectations, “it is too early to know what the net impact of the Covid-19 pandemic will be on our performance for the year.”Early SignsThe comments from Walgreens offer an early look at how businesses have been faring since the start of the coronavirus pandemic. While the company’s quarter ended on Feb. 29, before the worst of the Covid-19 outbreak in the U.S. and the most ambitious of the social-distancing efforts to contain it, executives indicated on the call with analysts that recent weeks have become more challenging.Walgreens executives stressed they think the situation is temporary, but Pessina said if the pandemic lasts more than a month its effects will be longer-lasting.“The world will be different later on,” he said. “Many things will have changed, their habits will be different.”Walgreens had already been trying to bolster its digital strategy before the outbreak. It has since made delivery free on its website and expanded a partnership with delivery service Postmates, among other efforts.In its second-quarter report, Walgreens said comparable sales at its U.S. stores rose 2.7% from a year earlier. At the pharmacy counter, sales rose 5.3%, which the company attributed to more expensive prescription drugs, more prescriptions filled and growth in its specialty business.Walgreens removed e-cigarettes from its U.S. stores last fall and has said it will de-emphasize tobacco. Those decisions weighed on results, as comparable retail sales rose 0.6% in the quarter, or 1.9% when excluding these products.Second-quarter adjusted earnings per share of $1.52, down from $1.64 a year earlier but better than the $1.46 Wall Street analysts expected, on average.(Adds more comments from Walgreens executives beginning in 10th paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
Walgreens (WBA) delivered earnings and revenue surprises of 4.83% and 1.48%, respectively, for the quarter ended February 2020. Do the numbers hold clues to what lies ahead for the stock?
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the second quarter of fiscal 2020, which ended February 29, 2020.
Investing.com - Walgreens Boots (NASDAQ:WBA) reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Anecdotal reports of clinical drug trials being disrupted by the coronavirus outbreak have caused concern for the life sciences sector at large, though it appears vaccine trials for COVID-19 won’t be affected, according to Moody’s.
Walgreens Boots Alliance (WBA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Solid prescription volume growth and brand inflation anticipated to have aided Walgreen Boots' (WBA) Retail Pharmacy USA performance in Q2.
Thousands of bathroom essentials will be distributed to NHS staff as well as schools and food banks to support the vulnerable.
To address the rising need for home delivery, Walgreens and Postmates have expanded on-demand delivery to now service consumers nationwide*. With this expansion, consumers in cities across the country can get health and wellness items, including select over-the-counter medications, and other household essentials and convenience products they need delivered to them from more than 7,000 Walgreens stores.
JPMorgan, Wells Fargo, Walgreens, Constellation Brands and Nike are part of Zacks Earnings Preview
As more and more people across the country continue to look for safe and convenient options to pick up daily essentials amidst the COVID-19 pandemic, Walgreens is now offering select products at its more than 7,300 pharmacy drive-thrus nationwide. The offering provides greater convenience while also helping to promote social distancing, and is another way Walgreens is helping to support patients and customers during this time.
Should investors think about buying Walgreens stock with the pharmacy and retail giant set to report its Q2 fiscal 2020 earnings results on Thursday, April 2?
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.